In PAH, overactivation of the SMAD2/3 signaling pathway in pulmonary arterial endothelial cells and smooth muscle cells, along with the suppression of SMAD1/5/8 signaling, jointly drives pulmonary vascular structural remodeling (54, 55). This evidence concerns the gene SMAD2 and pulmonary arterial hypertension.